These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Letter: Action of rifamycin S.V. on herpes viruses (varicella and herpes). Clinical trials]. Brunel D; Astruc J; Echenne B; Rodiere M Nouv Presse Med; 1976 Feb; 5(7):437. PubMed ID: 768920 [No Abstract] [Full Text] [Related]
4. Rifamycin SV and rifampicin exhibit differential inhibition of the hepatic rat organic anion transporting polypeptides, Oatp1 and Oatp2. Fattinger K; Cattori V; Hagenbuch B; Meier PJ; Stieger B Hepatology; 2000 Jul; 32(1):82-6. PubMed ID: 10869292 [TBL] [Abstract][Full Text] [Related]
5. Preliminary results of a clinical trial relative to the use of rifamycin SV in the treatment of herpes zoster. Bruni L; Califano A; De Angelis G; Montagnani A; Pisani M; Pezzarossa G; Pozzo G; Reali D; Rebora A; Zanca A J Int Med Res; 1980; 8(1):1-6. PubMed ID: 6987112 [TBL] [Abstract][Full Text] [Related]
8. [Value of rifamycin SV in the treatment of intraperitoneal suppurations]. Calderoli H; Van Peteghem R; Meyer C; Monteil H; Hollender LF Med Chir Dig; 1977; 6(6):395-400. PubMed ID: 926888 [No Abstract] [Full Text] [Related]
9. [Pharmacokinetics and biotransformation of rifamycins in the body of experimental animals]. Subbotina NA; Griaznova NS; Beliavskaia IV; Sazykin IuO; Navashin SM Antibiotiki; 1979 Aug; 24(8):590-7. PubMed ID: 485106 [TBL] [Abstract][Full Text] [Related]
10. Clinical improvement in ankylosing spondylitis with rifamycin SV infiltrations of peripheral joints. Caruso I; Cazzola M; Santandrea S J Int Med Res; 1992 Apr; 20(2):171-81. PubMed ID: 1521673 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of adenocarcinoma TA3 ascites tumor growth by rifamycin derivatives. Hughes AM; Tenforde TS; Calvin M; Bissell MJ; Tischler AN; Bennett EL Oncology; 1978; 35(2):76-82. PubMed ID: 652266 [TBL] [Abstract][Full Text] [Related]
12. [Herpes zoster infection in patients with lymphoid proliferative diseases]. Loginskiĭ VE Klin Med (Mosk); 1973 Jul; 51(7):40-2. PubMed ID: 4786260 [No Abstract] [Full Text] [Related]
14. [Cytosine arabinoside in the treatment of herpes simplex and chickenpox]. Pytel-Dabrowska T; Balcar-Boroń A; Nowaczyk-Michalak A Wiad Lek; 1980 Jun; 33(12):957-9. PubMed ID: 6932786 [No Abstract] [Full Text] [Related]
15. [Value of rifamycin sv used in situ in urologic surgery]. Patoir G; Lemaire G Lille Med; 1976 Jan; 21(1 suppl 1):8-12. PubMed ID: 1256231 [No Abstract] [Full Text] [Related]
16. [Experience in the clinical use of rifamycin SV]. Govorovich EA; Marshak AM; Iakovlev VP Antibiotiki; 1972 Nov; 17(11):1022-5. PubMed ID: 4664262 [No Abstract] [Full Text] [Related]
17. Rifamycin treatment of tuberculosis in a patient receiving atenolol: less interaction with rifabutin than with rifampin. Goldberg SV; Hanson D; Peloquin CA Clin Infect Dis; 2003 Aug; 37(4):607-8. PubMed ID: 12905149 [No Abstract] [Full Text] [Related]
18. [Agranulocytosis induced by rifamycin SV in a patient with Hodgkin's disease. Immunologic considerations and pathogenetic interpretations]. Fernandes D; Giacinti F G Batteriol Virol Immunol; 1982; 75(1-6):101-16. PubMed ID: 7187341 [TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetic profile of a new 3-azinomethyl rifamycin (SPA-S-565) in volunteers as compared with conventional rifampicin. Kelkar MS; Saraf AP; Bakhle DS; Nazare V; Ajay S; Hegde S; Lal HM; Cooverji ND; Bruzzese T Int J Clin Pharmacol Res; 1998; 18(3):137-43. PubMed ID: 9825270 [TBL] [Abstract][Full Text] [Related]